Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05176652
Other study ID # Soh-Med-21-12-21
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 6, 2021
Est. completion date December 6, 2022

Study information

Verified date December 2021
Source Sohag University
Contact Hossam Eldin Hassan ahmed, assisstant lecturer
Phone 01000393835
Email hossamhassan01000393835@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Changes in the optic nerve sheath diameter detected by ultrasound are considered an important manifestation of increased intracranial pressure . The normal optic nerve sheath diameter measures up to 5.0 mm and an average optic nerve sheath diameter more than 5 mm is considered abnormal and elevated intracranial pressure should be suspected.Cerebral edema have been demonstrated in 71% to 100% of magnetic resonance imaging in preeclamptic patients and an increase in optic nerve sheath diameter has been described in preeclamptic females compared to healthy pregnant females Therefore, Increased optic nerve sheath diameter can indirectly reflect the state of intracranial edema that could be a part of generalized edema of preeclampsia and it could be a possible marker of generalized tissue edema and fluid overload in these patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 6, 2022
Est. primary completion date October 6, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Systolic blood pressure of 160mm Hg or higher, or diastolic blood pressure of 110mm Hg or higher on 2 occasions at least 6 hours apart on bed rest. - Proteinuria =5g in a 24 hour urine specimen or =3+ on 2 random urine samples collected at least 4 hours apart. - patient acceptance - Accepted mental state of the patients Exclusion Criteria: - patient refusal to participate in the study - chronic kidney disease - chronic pulmonary disease - chronic cardiac disease - chronic hypertension - previous ocular operation and diseases

Study Design


Related Conditions & MeSH terms


Intervention

Radiation:
ultrasound
ultrasonographic assessment of optic nerve sheath diameter

Locations

Country Name City State
Egypt Hossam Eldin Hassan Ahmed Abdelghani Sohag
Egypt Hossam Eldin Hassan Ahmed Abdelghani Sohag
Egypt Hossam Eldin Hassan Ahmed Abdelghani Sohag

Sponsors (1)

Lead Sponsor Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary correlation between optic nerve sheath diameter and extravascular lung water correlation between ultrasound assessment of optic nerve sheath diameter and extravascular lung water up to 24 hours
See also
  Status Clinical Trial Phase
Completed NCT03661775 - Serum Magnesium Level Administration in Severe Pre-eclampsia Obese Pregnancy N/A
Completed NCT02164370 - Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach N/A
Recruiting NCT06219109 - Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia
Not yet recruiting NCT06385600 - Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia. N/A
Recruiting NCT05283473 - Serum Magnesium Concentration in Magnesium Sulfate Therapy for Severe Preeclampsia
Completed NCT01766089 - Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery Phase 2
Completed NCT06126068 - Comparison of Loading Dose Magnesium Sulphate With Prichard Regimen in the Management of Severe Preeclampsia and Eclampsia. N/A
Not yet recruiting NCT02314286 - Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following Delivery Phase 1/Phase 2
Completed NCT05310929 - Nitroglycerin Versus Labetalol in Acute Severe Pre-eclampsia N/A